<--- Back to Details
First PageDocument Content
Presidency of Lyndon B. Johnson / Health / Pharmaceutical sciences / Medicare Part D / Medicare / Pharmaceutical industry / Medicaid / Generic drug / Pharmacy benefit management / Healthcare reform in the United States / Pharmaceuticals policy / Federal assistance in the United States
Date: 2014-09-26 09:15:09
Presidency of Lyndon B. Johnson
Health
Pharmaceutical sciences
Medicare Part D
Medicare
Pharmaceutical industry
Medicaid
Generic drug
Pharmacy benefit management
Healthcare reform in the United States
Pharmaceuticals policy
Federal assistance in the United States

Costs under Medicare’s Prescription Drug Benefit and a Comparison with the Cost of Drugs under Medicaid Fee-for-Service

Add to Reading List

Source URL: www.cbo.gov

Download Document from Source Website

File Size: 294,52 KB

Share Document on Facebook

Similar Documents

FINECURE PHARMACEUTICALS LIMITED NOMINATION AND REMUNERATION POLICY I.  PREAMBLE

FINECURE PHARMACEUTICALS LIMITED NOMINATION AND REMUNERATION POLICY I. PREAMBLE

DocID: 1vhvU - View Document

For over 20 years, Health Policy Associates has been providing practical and highly efficient consulting solutions to companies involved in developing new medical device technologies, pharmaceuticals and biologics. Clin

For over 20 years, Health Policy Associates has been providing practical and highly efficient consulting solutions to companies involved in developing new medical device technologies, pharmaceuticals and biologics. Clin

DocID: 1vdpM - View Document

FINECURE PHARMACEUTICALS LIMITED POLICY ON ARCHIVAL OF DOCUMENTS 1. PREAMBLE The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (

FINECURE PHARMACEUTICALS LIMITED POLICY ON ARCHIVAL OF DOCUMENTS 1. PREAMBLE The Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR") came into force fr

DocID: 1v1UD - View Document

FINECURE PHARMACEUTICALS LTD. CIN: U24230GJ2005PLC045724 CORPORATE SOCIAL RESPONSIBILITY POLICY  Registered Office:

FINECURE PHARMACEUTICALS LTD. CIN: U24230GJ2005PLC045724 CORPORATE SOCIAL RESPONSIBILITY POLICY Registered Office:

DocID: 1uqeg - View Document

Privacy Policy Revised as of April 4, 2018 Welcome to www.minivelle.com, a web site owned by Noven Pharmaceuticals, Inc. (Noven, our, or we). This Privacy Policy is designed to tell you about our practices regarding coll

Privacy Policy Revised as of April 4, 2018 Welcome to www.minivelle.com, a web site owned by Noven Pharmaceuticals, Inc. (Noven, our, or we). This Privacy Policy is designed to tell you about our practices regarding coll

DocID: 1un1u - View Document